Dr. Kavita Patel joins ‘Fast Money’ to talk Eli Lilly’s GLP-1 entrant cutting diabetes risk, the weight-loss drugs sector as a whole, and more.
05:59
Tue, Aug 20 20246:18 PM EDT
Trending
- Aviation industry to have another hard year led by Boeing delays
- It could be time to rotate out of Big Tech
- U.S. opens probe into 2.6 million Tesla vehicles over remote driving feature
- Panama Unsettled by Trump Threat to Seize Canal
- 'Long overdue': Deepwater's Gene Munster applauds Meta's decision to dump fact-checking
- Indian stocks will benefit from the Trump 2.0 era, portfolio manager says
- Inflation returns to the picture
- McDonald's fighting against grocery spending with value deals, says Wedbush's Nick Setyan
Eli Lilly’s Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita Patel
